Careers Contact Us

Pfizer Financial Reports

Below you will find links to view Pfizer financial reports, including our latest performance report, annual reviews, and financial reports. These reports will help you to better understand Pfizer from both a financial and business standpoint.


Pfizer Annual Meeting of Shareholders — April 22, 2010

  • Audio Webcast  audio webcast — Annual Shareholder's Meeting
    Thursday, April 22, 2010
    8:30 AM E.D.T.
  • Download and Print Presentation (3.96 MB) PDF
  • Proxy Statement (PDF)
  • 2009 Annual Review (PDF | Interactive Version) — Pfizer. Where science comes to life. Where life meets science.
    Learn more about Our Path Forward (PDF)
  • 2009 Financial Report (PDF) — Our Financial Review, Consolidated Financial Statements and Notes to Consolidated Financial Statements
  • Corporate and Shareholder Information (PDF)
  • Form 10-K (PDF)
    Upon written request, we will provide without charge a copy of our Form 10-K for the fiscal year ended December 31, 2009, which contains the Company's audited financial statements.

    Requests should be directed to:
    Chief Counsel, Corporate Governance
    Pfizer Inc.
    235 East 42nd Street
    New York, NY 10017-5755

    In addition, we'll be adding the 2009 Q4 XBRL files here.

2008 Pfizer Annual Report to Shareholders

  • 2008 Annual Review (PDF | Interactive Version) — Doing Things Differently
  • 2008 Financial Report (PDF) — Our Financial Review, Consolidated Financial Statements and Notes to Consolidated Financial Statements

2007 Pfizer Annual Report to Shareholders

  • 2007 Annual Review (PDF | HTML) — Progress & Promise. Our Path Forward
  • 2007 Financial Report (PDF | HTML) — Our Financial Review, Consolidated Financial Statements and Notes to Consolidated Financial Statements

2006 Pfizer Annual Report to Shareholders

  • 2006 Annual Review (PDF | HTML) — Answers to pointed questions about Pfizer and about the way we approach human health
  • 2006 Financial Report (PDF | HTML) — Our financial review and financial statements

2005 Pfizer Annual Report to Shareholders

  • 2005 Annual Review (PDF | HTML) — Answers to pointed questions about Pfizer and about the way we approach human health
  • 2005 Financial Report (PDF | HTML) — Our financial review and financial statements

Pfizer Quarterly Corporate Performance — Second Quarter 2010

Pfizer Quarterly Corporate Performance — First Quarter 2010

Pfizer Quarterly Corporate Performance — Fourth Quarter 2009

Pfizer Quarterly Corporate Performance — Third Quarter 2009

Pfizer Quarterly Corporate Performance — Second Quarter 2009

Pfizer Quarterly Corporate Performance — First Quarter 2009

Pfizer Quarterly Corporate Performance — Fourth Quarter 2008

Pfizer Quarterly Corporate Performance — Third Quarter 2008

Pfizer Quarterly Corporate Performance — Second Quarter 2008

Pfizer Quarterly Corporate Performance — First Quarter 2008

Pfizer Quarterly Corporate Performance — Fourth Quarter 2007

Pfizer Quarterly Corporate Performance — Third Quarter 2007

Pfizer Quarterly Corporate Performance — Second Quarter 2007

Pfizer Quarterly Corporate Performance — First Quarter 2007


Pfizer to Acquire Wyeth


Stock Quote Disclaimer

20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.

pdf

If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page.
Text SizeAAA
Print
Pfizer Stock Price

Stock Symbol: PFE    Stock Exchange: NYSE

Stock Quote at: Jul 30 2010 4:00PM

Last  15.00Change  -0.09
%Change-0.60Vol.44,031,495
Day High15.1352 Wk. High20.36
Day Low14.8852 Wk. Low14.00
Open15.02Mkt. Cap(Bil)120.99
Prev. Close15.09

Track your investments with the Investor Dashboard.